FORWARD FEATURES CALENDAR

Healthcare & Life Sciences

Peppy raises GBP6.6m in Series A funding round

Peppy, a B2B digital health platform, has raised GBP6.6 million (USD10 million) in a Series A funding round.  Peppy provides tailored, expert-led support to individuals before they need to see a doctor, bridging the gap between online searches and hard-to-access clinical care. The investment was led by Felix Capital with

New Mountain Capital to acquire Flexan

An affiliate of New Mountain Capital (New Mountain) is to acquire Flexan, a medical device contract design and manufacturing organisation that specialises in silicone, thermoplastic, and specialty rubber components and devices.  Flexan will be acquired by ILC Dover, a New Mountain Capital portfolio company. The transaction is expected to close

Trilantic Europe invests in Smile Eyes Group

Trilantic Europe, a private equity firm focused on mid-market transactions in Europe, has invested in the Smile Eyes Group, a specialist in the German ophthalmology market headquartered in Munich.  The investment is structured as a partnership between Trilantic Europe, the two co-founders of Smile Eyes Dres. Wiltfang and Bechmann and

HFRI acquires zero balance recovery firm

Healthcare Financial Resources (HFRI), a specialist in healthcare accounts receivable (AR) recovery and resolution management, has acquired California-based STAT Revenue, a leading provider of zero balance (closed) claims review and recovery services for hospitals and health systems. The acquisition rounds out HFRI’s AR management capabilities by adding the final stage

HIG WhiteHorse refinances Grupo Recoletas

HIG WhiteHorse, a credit affiliate of global investment firm HIG Capital (HIG) has arranged a refinancing package for Grupo Hospitalario Recoletas (Recoletas), which includes a significant growth capital component. Recoletas is a family-owned Spanish private hospital operator headquartered in Valladolid, Spain, with a leading position in the Castilla y Leon

RiverGlade Capital makes three investments in first half of 2021

RiverGlade Capital (RiverGlade), a healthcare-focused private equity firm, has made threenew platform investments in the first six months of 2021 – Dynamic Infusion Therapy (DIT), Home Helpers Home Care (Home Helpers), and 2nd Chance Treatment Centers (2nd Chance).  “These investments are a result of RiverGlade’s efforts around several key themes

Novo Holdings co-leads Hemab’s USD55m Series A

Novo Holdings, an international life science investor, has co-led, alongside HealthCap and RA Capital Management, a USD55 million Series A financing in Hemab, a biotech company developing next generation therapeutics for serious underserved bleeding and thrombosis disorders. The Company was created in 2020 by Novo Seeds, the early stage investment

her1 Secures EUR5.5m in Series A fundraising round

Female wellness brand her1 has closed a Series A investment of EUR5.5 million, led by leading FoodTech investor Five Seasons Ventures.  The direct-to-consumer company provides natural and plant-based products to boost gut health and aid women’s health and beauty from within. The latest investment will enable the company to grow

Events

12 November, 2026 – 5:00 pm

Directory Listings